Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 12/19/2019 - 01:08 Home Read more about Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 12/19/2019 - 01:07 Home Read more about Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 12/19/2019 - 01:07 Home Read more about Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event Submitted by amarin on Mon, 12/16/2019 - 11:46 Home Read more about Report of unscheduled material events or corporate event
Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk Submitted by amarin on Fri, 12/13/2019 - 22:35 Home Read more about Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
Statement of changes in beneficial ownership of securities Submitted by amarin on Fri, 11/22/2019 - 01:52 Home Read more about Statement of changes in beneficial ownership of securities
Report of unscheduled material events or corporate event Submitted by amarin on Fri, 11/15/2019 - 11:38 Home Read more about Report of unscheduled material events or corporate event
Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 11/14/2019 - 09:29 Home Read more about Statement of changes in beneficial ownership of securities
Statement of changes in beneficial ownership of securities Submitted by amarin on Thu, 11/14/2019 - 09:24 Home Read more about Statement of changes in beneficial ownership of securities
Jefferies 2019 London Healthcare Conference Submitted by amarin on Mon, 11/11/2019 - 14:11 Home Read more about Jefferies 2019 London Healthcare Conference
